Judy Garber
朱迪·加伯
MD, MPH
Director, Cancer Risk and Prevention Clinic癌症风险与预防诊所主任
👥Biography 个人简介
Renowned hereditary breast cancer specialist at Dana-Farber, pioneering clinical programs in cancer risk assessment and prevention. Her research on BRCA1/2 management and chemoprevention has improved outcomes for high-risk individuals globally.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Hereditary Breast Cancer Prevention
Established landmark programs for high-risk women with BRCA mutations, integrating genetic counseling, surveillance, and chemoprevention strategies into standard care.
BRCA Clinical Research
Led pivotal clinical trials assessing risk-reducing interventions and targeted therapies in BRCA mutation carriers, directly influencing treatment guidelines.
Representative Works 代表性著作
Hereditary breast and ovarian cancer: current knowledge and future directions
Journal of Clinical Oncology (2005)
Comprehensive review shaping clinical approach to BRCA-related cancer prevention and early detection.
Risk-reducing salpingo-oophorectomy in women with BRCA1 or BRCA2 mutation
New England Journal of Medicine (2002)
Seminal study demonstrating risk reduction from prophylactic surgery in BRCA mutation carriers.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Mary-Claire King
University of Washington
Kenneth Offit
Memorial Sloan Kettering Cancer Center
Barbara Biesecker
RTI International / NHGRI
Bert Vogelstein
Johns Hopkins University School of Medicine
关注 朱迪·加伯 的研究动态
Follow Judy Garber's research updates
留下邮箱，当我们发布与 Judy Garber（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment